spot on @Red bar
important / critical, imo:
RAP "... has reached its target recruitment numbers for all study endpoints, including those for pneumonia, upper respiratory tract infection, lower respiratory tract involvement, croup, asthma/reactive airways disease and bronchiolitis." [my emphasis]
"Recruiting 1,157 paediatric patients in less than five months is a significant achievement and we are pleased to have reached the target enrolment numbers for all of our planned endpoints, which span a broad spectrum of childhood respiratory disease." [my emphasis]
well done RAP!
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides SMARTCOUGH-C May Study Update
Ann: ResApp Provides SMARTCOUGH-C May Study Update, page-41
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 103 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist